![Andrew Perlman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 M $ in data 31/05/2026
Andrew J.
Perlman is the founder of Innate Immune, Inc., founded in 2004, serving as Chief Executive Officer & Director.
Dr. Perlman is the founder of Velocity Pharmaceutical Development LLC, founded in 2011, serving as Chief Medical Officer & Managing Director.
Current jobs include CEO, Chief Financial Officer & Secretary at Spitfire Pharma, Inc.; Independent Director at Arcus Biosciences, Inc. since 2020; Managing Director & Head-Non-Clinical Development at X-37 Service Co., Inc.; and Advisor at Avestria Ventures Management LLC.
Former jobs include Chief Executive Officer & Director at Affymax, Inc. in 2002; Senior Director-Clinical Research at Genentech, Inc.; Independent Director at ISTA Pharmaceuticals, Inc. from 2006 to 2012; Executive Vice President at Tularik, Inc. from 1993 to 2004; Venture Partner at Presidio Partners; and President at Vitesse Biologics LLC.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from New York University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 48.325 ( 0,04% ) | 1 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 17/12/2020 |
Velocity Pharmaceutical Development LLC
 Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Develops pharmaceutical drugs | Fondatore | 01/01/2011 |
Spitfire Pharma, Inc.
 Spitfire Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Offers drug development and research services to improve the pharmaceutical properties of peptide drugs | Amministratore Delegato | - |
X-37 Service Co., Inc.
 X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of pharmaceutical drugs | Corporate Officer/Principal | - |
Avestria Ventures Management, LLC
 Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures invests in companies located in the United States. The firm focuses on health and life sciences sectors. It participates in early stage capital transactions. | Consulente / Consigliere | - |
| Società | Posizione | Fine |
|---|---|---|
Innate Immune, Inc.
 Innate Immune, Inc. Medical SpecialtiesHealth Technology Discovers and develops therapeutics | Fondatore | - |
Vitesse Biologics LLC
 Vitesse Biologics LLC Pharmaceuticals: MajorHealth Technology Develops antibody and protein-based therapeutics | Presidente | 01/12/2020 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Corporate Officer/Principal | 01/10/2004 |
| AFFYMAX, INC. | Amministratore Delegato | 01/10/2002 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 14 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets ophthalmic pharmaceutical products | Health Technology |
Innate Immune, Inc.
Innate Immune, Inc. Medical SpecialtiesHealth Technology Discovers and develops therapeutics | Health Technology |
Spitfire Pharma, Inc.
Spitfire Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Offers drug development and research services to improve the pharmaceutical properties of peptide drugs | Commercial Services |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Presidio Partners
 Presidio Partners Investment ManagersFinance Presidio Partners invests in companies located in the US. The firm targets companies operating in the fields of information technology, life sciences, and energy technology. They provide financing for early and late stage capital requirements. | Finance |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Develops pharmaceutical drugs | Retail Trade |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Vitesse Biologics LLC
Vitesse Biologics LLC Pharmaceuticals: MajorHealth Technology Develops antibody and protein-based therapeutics | Health Technology |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures invests in companies located in the United States. The firm focuses on health and life sciences sectors. It participates in early stage capital transactions. | Finance |
X-37 Service Co., Inc.
X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of pharmaceutical drugs | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
